Novotech

As the full harvest moon rises, we're shining a spotlight on Chuseok, a cherished Korean holiday that some of our team members are celebrating! Often called "Korean Thanksgiving," Chuseok is a time when families reunite to share sumptuous meals, ancestors are honored in heartfelt ceremonies and gratitude flows for the bountiful harvest. At Novotech, our strength lies in the rich tapestry of cultures woven by our global team. By embracing and understanding each other's traditions, we forge stronger bonds and broaden our perspectives. Whether Chuseok is part of your heritage or new to you, we invite you to reflect on its universal themes of gratitude, family, and community. #Chuseok #CulturalDiversity

#DidYouKnow Worldwide, Pancreatic Cancer (PC) ranks 12th in terms of total cancer incidence and 6th in cancer-related deaths? With a 5-year survival rate is between 2%-10%, PC has become a priority for the development of innovative treatment research. The future of PC treatment appears promising, with advancements in personalized medicine, early detection methods, and targeted biological therapies on the horizon. You can discover key insights into the current state and the latest advancements in PC research through the in-depth disease analysis provided in Novotech’s report, available for free download via this link: https://lnkd.in/dwHbnSRt #ClinicalResearch #PancreaticCancer #PDAC

Celebrate What Matters to You Choose alternate dates for allocated holidays that align with your culture. We support you in observing the celebrations that are most meaningful to you. Follow us to learn more about at Novotech #lifeatnovotech #cra #clinicaltrials #clinicalresearch #clinicalresearchassociate #cro

We are thrilled to invite you to an upcoming webinar titled "Empowering Patients to Overcome Challenges in Orphan Drug Development" on Thursday, 26 September 2024, at 15:00 CEST (9am EST / 9pm CST). This #webinar is a valuable opportunity for professionals in the medical research and clinical trials sector, particularly those working in rare disease and orphan drug development. Led by industry experts, the session will explore practical strategies and patient-centered approaches to advance orphan drug research. Key topics include: 🔹 Challenges and opportunities in the orphan drug market. 🔹 Patient-focused drug development strategies to improve trial engagement and reduce burden. 🔹 Operational considerations, including endpoint selection and cost management. 🔹 The importance of collaboration among sponsors, CROs, and patient advocacy groups. The event will be moderated by Scott Schliebner, Vice President of Clinical Development Consulting at Novotech, who will guide the discussion and ensure a dynamic exchange of ideas. Register now to join this important conversation and gain insights that can transform your approach to orphan drug development: https://lnkd.in/dJ3hiB5s Panelists: Scott Schliebner, VP- Drug Development Consulting, Novotech Afshawn C. ,Director, Program Management, Avidity Biosciences, Inc. Michal Meller, Project Management Director, Novotech Lauren Dahl, Senior Operations Manager, leapcure Ella Balasa, Patient Advocate, Consultant, Balasa Consulting We look forward to seeing you there. #OrphanDrugDevelopment #RareDiseaseResearch #Novotech

#DidYouKnow Gastric cancer (GC) ranks as the fifth most diagnosed cancer and the leading cause of cancer mortality? Since 2019, over 2,000 clinical trials have been initiated globally to explore new treatments. The focus is shifting from traditional chemotherapy to personalized approaches, including targeted therapies and immunotherapy. Advances in molecular diagnostics and biomarkers are paving the way for precision medicine. Ongoing research and collaboration are crucial for enhancing early detection, reducing recurrence, and optimizing GC treatments. You can discover key insights into the current state of GC research through the in-depth disease analysis provided in Novotech’s report, available for free download via this link: https://lnkd.in/dEEDZiQV #GastricCancer #PrecisionMedicine #CancerResearch

On Global Talent Acquisition Day, we celebrate Novotech's exceptional TA team! They don't just find talent; they create outstanding experiences for every candidate they meet. Their dedication to connecting great people with great opportunities while ensuring a positive journey is truly commendable. Thank you for being the friendly faces of Novotech and for your commitment to both our company and our candidates! #TalentAcquisitionDay #Lifeatnovotech #ClinicalTrials

Did you miss Novotech’s informative webinar on Biostatistics in the Development and Evaluation of Advanced Therapies in China? It’s not too late! The recording of this highly insightful event is now available on demand for you to watch at your convenience. Join Dr. David Ng (VP. Biometrics & Data Management) and Dr. Yafei Zhang (Director Biostatistics), with special guest Dr. Shan Xiao (Assoc. Director Biostatistics) from Takeda as they discuss: 🔹 Overview of Statistical Methods in Innovative Drug Development. 🔹 Statistical Analysis of Advanced Therapies for Rare Diseases and Case Studies. 🔹 Considerations of Innovative Statistical Methods in FDA Review. Like to know more? Access the recording directly: https://lnkd.in/gS_tg8PG #ClinicalTrials #BioStatistics #Novotech

Novotech was again certified as a WGEA Employer of Choice for Gender Equality in 2024. We're proud to continue our commitment to workplace inclusivity and equality. This recognition highlights our ongoing efforts to close the gender pay gap, prevent discrimination, and create an environment where all employees can thrive. Learn more: https://lnkd.in/guQrwQSw #GenderEquality #CRO #ClinicalTrials

Join a team that embraces new challenges and offers the chance to learn, evolve, and make a real impact in an inclusive and supportive environment. Join us Today! https://lnkd.in/gBX4Mmh2 #CRA #clinicaltrials #clinicalresearch #cro #lifeatnovotech

Exciting news! Novotech and Ozemio, as co-applicants, have won the Apex Award of Excellence for our Clinical Trial Monitoring Visit Simulation Training program. We were selected from over 1000 entries to receive the Electronic Media – Educational and Training award. This recognition highlights our commitment to innovative clinical research training. Proud of our team and thankful for the successful collaboration with Ozemio on this project! #ClinicalTrials #ClinicalResearch #CRO #CRA